BK virus risk study in kidney transplant patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at the type and genetic makeup of BK virus in kidney transplant patients and their donors. It aims to find patients at higher risk for a kidney infection caused by the virus, which could help improve monitoring and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a kidney transplant at least 3 months ago, but less than 2 years ago.
- You have had a positive test for BK virus in your urine with a high viral load (more than 3 log copies per mL).
- You are at least 18 years old.
- You are being followed at Grenoble Alpes University Hospital.
- You have health insurance coverage in France.
- You agree to have your data and samples used for this research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system responds to BK virus in people who have had a kidney transplant. The virus can sometimes cause problems with the new kidney, so researchers want to compare the immune responses in patients who have the virus with those who don't, and with healthy people.
This study is creating a registry to learn how the immune system responds to BK virus in people who have recently received a kidney transplant from a deceased donor. Researchers hope this information will help improve treatment for BK virus infections.
This study looks at whether BK virus can be found in the saliva of people who have had a kidney transplant, which could help doctors understand and monitor the virus more easily. If you've had a kidney transplant, this study may help improve care for people like you.
This study tests a new, unlicensed medicine (AIC468) to see if it can reduce BK virus levels in kidney transplant patients. BK virus can sometimes harm the new kidney, so this treatment aims to lower the virus and protect the transplant.
This early-phase study tests whether immune cells made from a donor (T cells) can treat BK virus infection in people whose immune system is weak after a stem cell transplant or chemotherapy. It may help control the virus causing bladder/urinary symptoms.
This study tests a new treatment using lab-made antibodies to treat BK virus infection. It may help by controlling the virus in adults who already test BK positive.
Hear when a new Nephropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.